Global Avian Influenza Vaccines Market Growth 2024-2030

Publisher Name :
Date: 04-Jan-2024
No. of pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period.

The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Avian Influenza Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Avian Influenza Vaccines market.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

Key Features:

The report on Avian Influenza Vaccines market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Avian Influenza Vaccines market. It may include historical data, market Segmentation by Type (e.g., H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Avian Influenza Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Avian Influenza Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Avian Influenza Vaccines industry. This include advancements in Avian Influenza Vaccines technology, Avian Influenza Vaccines new entrants, Avian Influenza Vaccines new investment, and other innovations that are shaping the future of Avian Influenza Vaccines.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Avian Influenza Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Avian Influenza Vaccines product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Avian Influenza Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Avian Influenza Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Avian Influenza Vaccines market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Avian Influenza Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Avian Influenza Vaccines market.

Market Segmentation:

Avian Influenza Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type

- H5+H7 Avian Influenza Vaccines

- H9 Avian Influenza Vaccines

Segmentation by application

- Chicken Avian Influenza Vaccines

- Duck & Goose Avian Influenza Vaccines

- Other

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Merial

- QYH Biotech

- DHN

- HVRI

- CEVA

- Elanco (Lohmann )

- Yebio

- Zoetis

- FATRO

- Kyoto Biken

- CAVAC

- Ringpu Biology

- Vaksindo

- ChengDu Tecbond

- Sindh Poultry Vaccine Centre

- Merck Animal Health

- Medion

- Avimex Animal Health

- JOVAC

- Bio-Labs

Key Questions Addressed in this Report

What is the 10-year outlook for the global Avian Influenza Vaccines market?

What factors are driving Avian Influenza Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Avian Influenza Vaccines market opportunities vary by end market size?

How does Avian Influenza Vaccines break out type, application?

Global Avian Influenza Vaccines Market Growth 2024-2030

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Avian Influenza Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Avian Influenza Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Avian Influenza Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Avian Influenza Vaccines Segment by Type
2.2.1 H5+H7 Avian Influenza Vaccines
2.2.2 H9 Avian Influenza Vaccines
2.3 Avian Influenza Vaccines Sales by Type
2.3.1 Global Avian Influenza Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Avian Influenza Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Avian Influenza Vaccines Sale Price by Type (2019-2024)
2.4 Avian Influenza Vaccines Segment by Application
2.4.1 Chicken Avian Influenza Vaccines
2.4.2 Duck & Goose Avian Influenza Vaccines
2.4.3 Other
2.5 Avian Influenza Vaccines Sales by Application
2.5.1 Global Avian Influenza Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Avian Influenza Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Avian Influenza Vaccines Sale Price by Application (2019-2024)
3 Global Avian Influenza Vaccines by Company
3.1 Global Avian Influenza Vaccines Breakdown Data by Company
3.1.1 Global Avian Influenza Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Avian Influenza Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Avian Influenza Vaccines Revenue by Company (2019-2024)
3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Avian Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Avian Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Avian Influenza Vaccines Product Location Distribution
3.4.2 Players Avian Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Avian Influenza Vaccines by Geographic Region
4.1 World Historic Avian Influenza Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Avian Influenza Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Avian Influenza Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Avian Influenza Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Avian Influenza Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Avian Influenza Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Avian Influenza Vaccines Sales Growth
4.4 APAC Avian Influenza Vaccines Sales Growth
4.5 Europe Avian Influenza Vaccines Sales Growth
4.6 Middle East & Africa Avian Influenza Vaccines Sales Growth
5 Americas
5.1 Americas Avian Influenza Vaccines Sales by Country
5.1.1 Americas Avian Influenza Vaccines Sales by Country (2019-2024)
5.1.2 Americas Avian Influenza Vaccines Revenue by Country (2019-2024)
5.2 Americas Avian Influenza Vaccines Sales by Type
5.3 Americas Avian Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Avian Influenza Vaccines Sales by Region
6.1.1 APAC Avian Influenza Vaccines Sales by Region (2019-2024)
6.1.2 APAC Avian Influenza Vaccines Revenue by Region (2019-2024)
6.2 APAC Avian Influenza Vaccines Sales by Type
6.3 APAC Avian Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Avian Influenza Vaccines by Country
7.1.1 Europe Avian Influenza Vaccines Sales by Country (2019-2024)
7.1.2 Europe Avian Influenza Vaccines Revenue by Country (2019-2024)
7.2 Europe Avian Influenza Vaccines Sales by Type
7.3 Europe Avian Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Avian Influenza Vaccines by Country
8.1.1 Middle East & Africa Avian Influenza Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Avian Influenza Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Avian Influenza Vaccines Sales by Type
8.3 Middle East & Africa Avian Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Avian Influenza Vaccines
10.3 Manufacturing Process Analysis of Avian Influenza Vaccines
10.4 Industry Chain Structure of Avian Influenza Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Avian Influenza Vaccines Distributors
11.3 Avian Influenza Vaccines Customer
12 World Forecast Review for Avian Influenza Vaccines by Geographic Region
12.1 Global Avian Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Avian Influenza Vaccines Forecast by Region (2025-2030)
12.1.2 Global Avian Influenza Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Avian Influenza Vaccines Forecast by Type
12.7 Global Avian Influenza Vaccines Forecast by Application
13 Key Players Analysis
13.1 Merial
13.1.1 Merial Company Information
13.1.2 Merial Avian Influenza Vaccines Product Portfolios and Specifications
13.1.3 Merial Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merial Main Business Overview
13.1.5 Merial Latest Developments
13.2 QYH Biotech
13.2.1 QYH Biotech Company Information
13.2.2 QYH Biotech Avian Influenza Vaccines Product Portfolios and Specifications
13.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 QYH Biotech Main Business Overview
13.2.5 QYH Biotech Latest Developments
13.3 DHN
13.3.1 DHN Company Information
13.3.2 DHN Avian Influenza Vaccines Product Portfolios and Specifications
13.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 DHN Main Business Overview
13.3.5 DHN Latest Developments
13.4 HVRI
13.4.1 HVRI Company Information
13.4.2 HVRI Avian Influenza Vaccines Product Portfolios and Specifications
13.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 HVRI Main Business Overview
13.4.5 HVRI Latest Developments
13.5 CEVA
13.5.1 CEVA Company Information
13.5.2 CEVA Avian Influenza Vaccines Product Portfolios and Specifications
13.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CEVA Main Business Overview
13.5.5 CEVA Latest Developments
13.6 Elanco (Lohmann )
13.6.1 Elanco (Lohmann ) Company Information
13.6.2 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolios and Specifications
13.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Elanco (Lohmann ) Main Business Overview
13.6.5 Elanco (Lohmann ) Latest Developments
13.7 Yebio
13.7.1 Yebio Company Information
13.7.2 Yebio Avian Influenza Vaccines Product Portfolios and Specifications
13.7.3 Yebio Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Yebio Main Business Overview
13.7.5 Yebio Latest Developments
13.8 Zoetis
13.8.1 Zoetis Company Information
13.8.2 Zoetis Avian Influenza Vaccines Product Portfolios and Specifications
13.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zoetis Main Business Overview
13.8.5 Zoetis Latest Developments
13.9 FATRO
13.9.1 FATRO Company Information
13.9.2 FATRO Avian Influenza Vaccines Product Portfolios and Specifications
13.9.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 FATRO Main Business Overview
13.9.5 FATRO Latest Developments
13.10 Kyoto Biken
13.10.1 Kyoto Biken Company Information
13.10.2 Kyoto Biken Avian Influenza Vaccines Product Portfolios and Specifications
13.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Kyoto Biken Main Business Overview
13.10.5 Kyoto Biken Latest Developments
13.11 CAVAC
13.11.1 CAVAC Company Information
13.11.2 CAVAC Avian Influenza Vaccines Product Portfolios and Specifications
13.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 CAVAC Main Business Overview
13.11.5 CAVAC Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Avian Influenza Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 Vaksindo
13.13.1 Vaksindo Company Information
13.13.2 Vaksindo Avian Influenza Vaccines Product Portfolios and Specifications
13.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Vaksindo Main Business Overview
13.13.5 Vaksindo Latest Developments
13.14 ChengDu Tecbond
13.14.1 ChengDu Tecbond Company Information
13.14.2 ChengDu Tecbond Avian Influenza Vaccines Product Portfolios and Specifications
13.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ChengDu Tecbond Main Business Overview
13.14.5 ChengDu Tecbond Latest Developments
13.15 Sindh Poultry Vaccine Centre
13.15.1 Sindh Poultry Vaccine Centre Company Information
13.15.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolios and Specifications
13.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Sindh Poultry Vaccine Centre Main Business Overview
13.15.5 Sindh Poultry Vaccine Centre Latest Developments
13.16 Merck Animal Health
13.16.1 Merck Animal Health Company Information
13.16.2 Merck Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Merck Animal Health Main Business Overview
13.16.5 Merck Animal Health Latest Developments
13.17 Medion
13.17.1 Medion Company Information
13.17.2 Medion Avian Influenza Vaccines Product Portfolios and Specifications
13.17.3 Medion Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Medion Main Business Overview
13.17.5 Medion Latest Developments
13.18 Avimex Animal Health
13.18.1 Avimex Animal Health Company Information
13.18.2 Avimex Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Avimex Animal Health Main Business Overview
13.18.5 Avimex Animal Health Latest Developments
13.19 JOVAC
13.19.1 JOVAC Company Information
13.19.2 JOVAC Avian Influenza Vaccines Product Portfolios and Specifications
13.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 JOVAC Main Business Overview
13.19.5 JOVAC Latest Developments
13.20 Bio-Labs
13.20.1 Bio-Labs Company Information
13.20.2 Bio-Labs Avian Influenza Vaccines Product Portfolios and Specifications
13.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Bio-Labs Main Business Overview
13.20.5 Bio-Labs Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Avian Influenza Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Avian Influenza Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of H5+H7 Avian Influenza Vaccines
Table 4. Major Players of H9 Avian Influenza Vaccines
Table 5. Global Avian Influenza Vaccines Sales by Type (2019-2024) & (M Doses)
Table 6. Global Avian Influenza Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Avian Influenza Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Avian Influenza Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Avian Influenza Vaccines Sale Price by Type (2019-2024) & (USD/K Doses)
Table 10. Global Avian Influenza Vaccines Sales by Application (2019-2024) & (M Doses)
Table 11. Global Avian Influenza Vaccines Sales Market Share by Application (2019-2024)
Table 12. Global Avian Influenza Vaccines Revenue by Application (2019-2024)
Table 13. Global Avian Influenza Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Avian Influenza Vaccines Sale Price by Application (2019-2024) & (USD/K Doses)
Table 15. Global Avian Influenza Vaccines Sales by Company (2019-2024) & (M Doses)
Table 16. Global Avian Influenza Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Avian Influenza Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Avian Influenza Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Avian Influenza Vaccines Sale Price by Company (2019-2024) & (USD/K Doses)
Table 20. Key Manufacturers Avian Influenza Vaccines Producing Area Distribution and Sales Area
Table 21. Players Avian Influenza Vaccines Products Offered
Table 22. Avian Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Avian Influenza Vaccines Sales by Geographic Region (2019-2024) & (M Doses)
Table 26. Global Avian Influenza Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Avian Influenza Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Avian Influenza Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Avian Influenza Vaccines Sales by Country/Region (2019-2024) & (M Doses)
Table 30. Global Avian Influenza Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Avian Influenza Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Avian Influenza Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)
Table 34. Americas Avian Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Avian Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Avian Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 37. Americas Avian Influenza Vaccines Sales by Type (2019-2024) & (M Doses)
Table 38. Americas Avian Influenza Vaccines Sales by Application (2019-2024) & (M Doses)
Table 39. APAC Avian Influenza Vaccines Sales by Region (2019-2024) & (M Doses)
Table 40. APAC Avian Influenza Vaccines Sales Market Share by Region (2019-2024)
Table 41. APAC Avian Influenza Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Avian Influenza Vaccines Revenue Market Share by Region (2019-2024)
Table 43. APAC Avian Influenza Vaccines Sales by Type (2019-2024) & (M Doses)
Table 44. APAC Avian Influenza Vaccines Sales by Application (2019-2024) & (M Doses)
Table 45. Europe Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)
Table 46. Europe Avian Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 47. Europe Avian Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Avian Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Europe Avian Influenza Vaccines Sales by Type (2019-2024) & (M Doses)
Table 50. Europe Avian Influenza Vaccines Sales by Application (2019-2024) & (M Doses)
Table 51. Middle East & Africa Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)
Table 52. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Avian Influenza Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Avian Influenza Vaccines Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Avian Influenza Vaccines Sales by Type (2019-2024) & (M Doses)
Table 56. Middle East & Africa Avian Influenza Vaccines Sales by Application (2019-2024) & (M Doses)
Table 57. Key Market Drivers & Growth Opportunities of Avian Influenza Vaccines
Table 58. Key Market Challenges & Risks of Avian Influenza Vaccines
Table 59. Key Industry Trends of Avian Influenza Vaccines
Table 60. Avian Influenza Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Avian Influenza Vaccines Distributors List
Table 63. Avian Influenza Vaccines Customer List
Table 64. Global Avian Influenza Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
Table 65. Global Avian Influenza Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Avian Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 67. Americas Avian Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Avian Influenza Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
Table 69. APAC Avian Influenza Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Avian Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 71. Europe Avian Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Avian Influenza Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 73. Middle East & Africa Avian Influenza Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Avian Influenza Vaccines Sales Forecast by Type (2025-2030) & (M Doses)
Table 75. Global Avian Influenza Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Avian Influenza Vaccines Sales Forecast by Application (2025-2030) & (M Doses)
Table 77. Global Avian Influenza Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merial Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Merial Avian Influenza Vaccines Product Portfolios and Specifications
Table 80. Merial Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 81. Merial Main Business
Table 82. Merial Latest Developments
Table 83. QYH Biotech Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. QYH Biotech Avian Influenza Vaccines Product Portfolios and Specifications
Table 85. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 86. QYH Biotech Main Business
Table 87. QYH Biotech Latest Developments
Table 88. DHN Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. DHN Avian Influenza Vaccines Product Portfolios and Specifications
Table 90. DHN Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 91. DHN Main Business
Table 92. DHN Latest Developments
Table 93. HVRI Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. HVRI Avian Influenza Vaccines Product Portfolios and Specifications
Table 95. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 96. HVRI Main Business
Table 97. HVRI Latest Developments
Table 98. CEVA Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. CEVA Avian Influenza Vaccines Product Portfolios and Specifications
Table 100. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 101. CEVA Main Business
Table 102. CEVA Latest Developments
Table 103. Elanco (Lohmann ) Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolios and Specifications
Table 105. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 106. Elanco (Lohmann ) Main Business
Table 107. Elanco (Lohmann ) Latest Developments
Table 108. Yebio Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Avian Influenza Vaccines Product Portfolios and Specifications
Table 110. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. Zoetis Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Zoetis Avian Influenza Vaccines Product Portfolios and Specifications
Table 115. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 116. Zoetis Main Business
Table 117. Zoetis Latest Developments
Table 118. FATRO Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. FATRO Avian Influenza Vaccines Product Portfolios and Specifications
Table 120. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 121. FATRO Main Business
Table 122. FATRO Latest Developments
Table 123. Kyoto Biken Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Kyoto Biken Avian Influenza Vaccines Product Portfolios and Specifications
Table 125. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 126. Kyoto Biken Main Business
Table 127. Kyoto Biken Latest Developments
Table 128. CAVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. CAVAC Avian Influenza Vaccines Product Portfolios and Specifications
Table 130. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 131. CAVAC Main Business
Table 132. CAVAC Latest Developments
Table 133. Ringpu Biology Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Ringpu Biology Avian Influenza Vaccines Product Portfolios and Specifications
Table 135. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 136. Ringpu Biology Main Business
Table 137. Ringpu Biology Latest Developments
Table 138. Vaksindo Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Vaksindo Avian Influenza Vaccines Product Portfolios and Specifications
Table 140. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 141. Vaksindo Main Business
Table 142. Vaksindo Latest Developments
Table 143. ChengDu Tecbond Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. ChengDu Tecbond Avian Influenza Vaccines Product Portfolios and Specifications
Table 145. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 146. ChengDu Tecbond Main Business
Table 147. ChengDu Tecbond Latest Developments
Table 148. Sindh Poultry Vaccine Centre Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolios and Specifications
Table 150. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 151. Sindh Poultry Vaccine Centre Main Business
Table 152. Sindh Poultry Vaccine Centre Latest Developments
Table 153. Merck Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Merck Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 155. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 156. Merck Animal Health Main Business
Table 157. Merck Animal Health Latest Developments
Table 158. Medion Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Medion Avian Influenza Vaccines Product Portfolios and Specifications
Table 160. Medion Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 161. Medion Main Business
Table 162. Medion Latest Developments
Table 163. Avimex Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Avimex Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 165. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 166. Avimex Animal Health Main Business
Table 167. Avimex Animal Health Latest Developments
Table 168. JOVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. JOVAC Avian Influenza Vaccines Product Portfolios and Specifications
Table 170. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 171. JOVAC Main Business
Table 172. JOVAC Latest Developments
Table 173. Bio-Labs Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Bio-Labs Avian Influenza Vaccines Product Portfolios and Specifications
Table 175. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 176. Bio-Labs Main Business
Table 177. Bio-Labs Latest Developments
List of Figures
Figure 1. Picture of Avian Influenza Vaccines
Figure 2. Avian Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avian Influenza Vaccines Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Avian Influenza Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Avian Influenza Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of H5+H7 Avian Influenza Vaccines
Figure 10. Product Picture of H9 Avian Influenza Vaccines
Figure 11. Global Avian Influenza Vaccines Sales Market Share by Type in 2023
Figure 12. Global Avian Influenza Vaccines Revenue Market Share by Type (2019-2024)
Figure 13. Avian Influenza Vaccines Consumed in Chicken Avian Influenza Vaccines
Figure 14. Global Avian Influenza Vaccines Market: Chicken Avian Influenza Vaccines (2019-2024) & (M Doses)
Figure 15. Avian Influenza Vaccines Consumed in Duck & Goose Avian Influenza Vaccines
Figure 16. Global Avian Influenza Vaccines Market: Duck & Goose Avian Influenza Vaccines (2019-2024) & (M Doses)
Figure 17. Avian Influenza Vaccines Consumed in Other
Figure 18. Global Avian Influenza Vaccines Market: Other (2019-2024) & (M Doses)
Figure 19. Global Avian Influenza Vaccines Sales Market Share by Application (2023)
Figure 20. Global Avian Influenza Vaccines Revenue Market Share by Application in 2023
Figure 21. Avian Influenza Vaccines Sales Market by Company in 2023 (M Doses)
Figure 22. Global Avian Influenza Vaccines Sales Market Share by Company in 2023
Figure 23. Avian Influenza Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Avian Influenza Vaccines Revenue Market Share by Company in 2023
Figure 25. Global Avian Influenza Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Avian Influenza Vaccines Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Avian Influenza Vaccines Sales 2019-2024 (M Doses)
Figure 28. Americas Avian Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 29. APAC Avian Influenza Vaccines Sales 2019-2024 (M Doses)
Figure 30. APAC Avian Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. Europe Avian Influenza Vaccines Sales 2019-2024 (M Doses)
Figure 32. Europe Avian Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Avian Influenza Vaccines Sales 2019-2024 (M Doses)
Figure 34. Middle East & Africa Avian Influenza Vaccines Revenue 2019-2024 ($ Millions)
Figure 35. Americas Avian Influenza Vaccines Sales Market Share by Country in 2023
Figure 36. Americas Avian Influenza Vaccines Revenue Market Share by Country in 2023
Figure 37. Americas Avian Influenza Vaccines Sales Market Share by Type (2019-2024)
Figure 38. Americas Avian Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 39. United States Avian Influenza Vaccine
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs